Author: Peggy Dennis
-

Perspective: Life sciences in peril
The unintended consequences of legislation are often as important as the original purpose. Two bills scheduled to be considered next month by the U.S. Senate’s Committee on Health, Education, Labor, and Pensions (HELP) are well-intentioned but would undermine Colorado’s thriving life sciences industry, interfere with the drug discovery pipeline and potentially risk patient safety. Each…





